ArticlePediatric blood & cancer2019

Preclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenografts.

Luke Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.